Axon Enterprise, Inc. (NASDAQ:AXON) Holdings Trimmed by Capital International Investors

Capital International Investors reduced its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 92.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 101,475 shares of the biotechnology company's stock after selling 1,207,000 shares during the quarter. Capital International Investors owned approximately 0.13% of Axon Enterprise worth $60,309,000 as of its most recent filing with the SEC.

Several other hedge funds also recently added to or reduced their stakes in AXON. Vanguard Group Inc. raised its stake in Axon Enterprise by 3.4% during the 4th quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company's stock valued at $5,019,886,000 after acquiring an additional 275,959 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Axon Enterprise by 3.7% during the 4th quarter. Geode Capital Management LLC now owns 1,847,925 shares of the biotechnology company's stock worth $1,095,542,000 after acquiring an additional 65,097 shares in the last quarter. Alliancebernstein L.P. increased its position in shares of Axon Enterprise by 273.8% in the fourth quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company's stock valued at $659,128,000 after buying an additional 812,337 shares in the last quarter. Norges Bank acquired a new stake in shares of Axon Enterprise in the fourth quarter valued at approximately $482,081,000. Finally, GQG Partners LLC purchased a new stake in shares of Axon Enterprise in the fourth quarter valued at $478,349,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Axon Enterprise Price Performance

Shares of Axon Enterprise stock traded up $21.38 during trading on Wednesday, hitting $576.90. The stock had a trading volume of 492,669 shares, compared to its average volume of 783,796. The business has a fifty day moving average of $551.62 and a two-hundred day moving average of $568.27. Axon Enterprise, Inc. has a fifty-two week low of $273.52 and a fifty-two week high of $715.99. The firm has a market cap of $44.91 billion, a P/E ratio of 149.07, a PEG ratio of 5.17 and a beta of 1.13. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.

Insider Activity

In other news, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction on Monday, April 21st. The stock was sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the completion of the sale, the chief executive officer now owns 3,063,982 shares in the company, valued at approximately $1,657,583,622.18. This represents a 0.33 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Jeri Williams sold 307 shares of the firm's stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the sale, the director now directly owns 1,627 shares of the company's stock, valued at approximately $899,275.44. This represents a 15.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 6.10% of the company's stock.

Analysts Set New Price Targets

AXON has been the subject of several analyst reports. Needham & Company LLC reiterated a "buy" rating and issued a $600.00 price target on shares of Axon Enterprise in a report on Wednesday. Northcoast Research lowered Axon Enterprise from a "buy" rating to a "neutral" rating in a research report on Wednesday, February 19th. The Goldman Sachs Group lifted their target price on Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a research report on Monday, January 27th. JMP Securities restated an "outperform" rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Finally, TD Cowen initiated coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They set a "buy" rating and a $700.00 target price for the company. One analyst has rated the stock with a sell rating, two have assigned a hold rating and ten have issued a buy rating to the company's stock. According to MarketBeat, Axon Enterprise presently has a consensus rating of "Moderate Buy" and an average price target of $626.45.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.